Aclaris Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ACRS and other ETFs, options, and stocks.

About ACRS

Aclaris Therapeutics, Inc. operates as a dermatologist-led biopharmaceutical company, which engages in identifying, developing, and commercializing novel drugs to address the needs in medical and aesthetic dermatology and immunology. It operates through the Therapeutics and Contract Research segments. 

CEO
Neal S. Walker
CEONeal S. Walker
Employees
64
Employees64
Headquarters
Wayne, Pennsylvania
HeadquartersWayne, Pennsylvania
Founded
2012
Founded2012
Employees
64
Employees64

ACRS Key Statistics

Market cap
387.23M
Market cap387.23M
Price-Earnings ratio
-2.61
Price-Earnings ratio-2.61
Dividend yield
Dividend yield
Average volume
5.43M
Average volume5.43M
High today
$3.59
High today$3.59
Low today
$3.42
Low today$3.42
Open price
$3.55
Open price$3.55
Volume
1.03M
Volume1.03M
52 Week high
$4.89
52 Week high$4.89
52 Week low
$1.05
52 Week low$1.05

Stock Snapshot

With a market cap of 387.23M, Aclaris Therapeutics(ACRS) trades at $3.49. The stock has a price-to-earnings ratio of -2.61.

On 2026-02-03, Aclaris Therapeutics(ACRS) stock moved within a range of $3.42 to $3.59. With shares now at $3.49, the stock is trading +2.0% above its intraday low and -2.7% below the session's peak.

Trading volume for Aclaris Therapeutics(ACRS) stock has reached 1.03M, versus its average volume of 5.43M.

Over the past 52 weeks, Aclaris Therapeutics(ACRS) stock has traded between a high of $4.89 and a low of $1.05.

Over the past 52 weeks, Aclaris Therapeutics(ACRS) stock has traded between a high of $4.89 and a low of $1.05.

ACRS News

Simply Wall St 14h
There's Reason For Concern Over Aclaris Therapeutics, Inc.'s Massive 25% Price Jump

Aclaris Therapeutics, Inc. ( ) shares have continued their recent momentum with a 25% gain in the last month alone. Looking back a bit further, it's encouraging...

There's Reason For Concern Over Aclaris Therapeutics, Inc.'s Massive 25% Price Jump

Analyst ratings

88%

of 8 ratings
Buy
87.5%
Hold
12.5%
Sell
0%

People also own

Based on the portfolios of people who own ACRS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.